- Home
- FLGC vs IBIO Comparison
FLGC vs IBIO Comparison
Compare FLGC & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- IBIO
- Stock Information
- Founded
- FLGC 2019
- IBIO 2008
- Country
- FLGC United States
- IBIO United States
- Employees
- FLGC N/A
- IBIO N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- IBIO Health Care
- Exchange
- FLGC Nasdaq
- IBIO Nasdaq
- Market Cap
- FLGC 15.9M
- IBIO 15.9M
- IPO Year
- FLGC 2021
- IBIO N/A
- Fundamental
- Price
- FLGC $0.61
- IBIO $0.71
- Analyst Decision
- FLGC Buy
- IBIO Strong Buy
- Analyst Count
- FLGC 2
- IBIO 3
- Target Price
- FLGC $4.00
- IBIO $4.87
- AVG Volume (30 Days)
- FLGC 106.1K
- IBIO 5.3M
- Earning Date
- FLGC 08-11-2025
- IBIO 05-02-2025
- Dividend Yield
- FLGC N/A
- IBIO N/A
- EPS Growth
- FLGC N/A
- IBIO N/A
- EPS
- FLGC N/A
- IBIO N/A
- Revenue
- FLGC $53,260,000.00
- IBIO $375,000.00
- Revenue This Year
- FLGC N/A
- IBIO $36.00
- Revenue Next Year
- FLGC N/A
- IBIO N/A
- P/E Ratio
- FLGC N/A
- IBIO N/A
- Revenue Growth
- FLGC N/A
- IBIO 650.00
- 52 Week Low
- FLGC $0.42
- IBIO $0.64
- 52 Week High
- FLGC $2.11
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- FLGC 42.89
- IBIO 37.70
- Support Level
- FLGC $0.62
- IBIO $0.68
- Resistance Level
- FLGC $0.72
- IBIO $1.04
- Average True Range (ATR)
- FLGC 0.06
- IBIO 0.12
- MACD
- FLGC -0.01
- IBIO -0.00
- Stochastic Oscillator
- FLGC 14.79
- IBIO 7.89
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.